Yiling Pharma’s Traditional Chinese Medicine Added to Government's Recommended Drugs For COVID-19 - Marketscreener.com

1 year ago 51

Homepage Equities China Shenzhen Stock Exchange Shijiazhuang Yiling Pharmaceutical Co., Ltd. News Summary     002603   CNE1000015S0 (002603) Add to my list   Report End-of-day punctuation Shenzhen Stock Exchange  -  2023-01-05 29.28 CNY   -1.01% 01/08 Yiling Pharma’s Traditional Chinese Medicine Added to Government's Recommended Drugs For COVID-19 MT 01/03 Gloom and boom: Fund managers' apical picks for 2023 RE 2022 Chinese Shares End Year With Modest Gains; Two Shenzhen Debutants Post Mixed Results MT Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds   Summary Most relevant All News Other languages Press Releases Official Publications Sector news 01/08/2023 | 11:12pm EST MT Newswires 2023 Stocks mentioned successful the article Change Last 1st jan. SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.  -1.01% 29.28 -2.27% UNITED STATES DOLLAR (B) / CHINESE YUAN IN HONG KONG (USD/CNH)  -0.44% 6.79574 -1.31% All quality about SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. 01/08 Yiling Pharma’s Traditional Chinese Medicine Added to Government's Recommended Dr.. MT 01/03 Gloom and boom: Fund managers' apical picks for 2023 RE 2022 Chinese Shares End Year With Modest Gains; Two Shenzhen Debutants Post Mixed Results MT 2022 Health Care Tick Down connected Growth Fears -- Health Care Roundup DJ 2022 North American Morning Briefing: China Optimism Gives Bo.. DJ 2022 China stocks leap connected easing COVID curbs RE 2022 China stocks emergence connected further eased COVID rules RE 2022 Shijiazhuang Yiling Pharma Secures Regulatory Nod For Traditional Chinese Medicine Tria.. MT 2022 Yiling Pharma Denies Claims That COVID-19 Drug May Cause Liver Injury MT 2022 Shijiazhuang Yiling Pharmaceutical's Anti-Respiratory Disease Drug Enters Singaporean M.. MT More news Financials Sales 2022 11 204 M 1 639 M 1 639 M Net income 2022 1 646 M 241 M 241 M Net currency 2022 9,50 M 1,39 M 1,39 M P/E ratio 2022 29,8x Yield 2022 1,28% Capitalization 48 918 M 7 155 M 7 155 M EV / Sales 2022 4,37x EV / Sales 2023 3,66x Nbr of Employees 15 155 Free-Float 41,0% More Financials Chart SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Duration : Period : Full-screen chart Technical investigation trends SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Short Term Mid-Term Long Term Trends Bearish Neutral Neutral Technical analysis Income Statement Evolution More Financials Consensus Sell Buy Mean consensus BUY Number of Analysts 4 Last Close Price 29,28 CNY Average people price 33,05 CNY Spread / Average Target 12,9% Consensus EPS Revisions More Estimates Revisions Managers and Directors Xiang Jun Wu Director & General Manager-Marketing Center Chen Guang Li Chief Financial Officer & Director Yi Ling Wu Chairman Xue Dong Gao Chairman-Supervisory Board Zhen Wang Independent Director More astir the company Sector and Competitors 1st jan. Capi. (M$) SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. -2.27% 7 155 DONG-E-E-JIAO CO.,LTD. -2.26% 3 747 TASLY PHARMACEUTICAL GROUP CO., LTD 4.55% 2 445 PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK -1.32% 1 433 GUIZHOU XINBANG PHARMACEUTICAL CO., LTD. 2.34% 1 368 CANOPY GROWTH CORPORATION 1.91% 1 155 More Results

1. Homepage
2. Health
3. Yiling Pharma’s Traditional Chinese Medicine Added to Government's Recommended Drugs For COVID-19 - Marketscreener.com